NeoCart Phase 3 Clinical Trial Enrollment Update

Histogenics has now enrolled ~3/4 (183) of 245 patients required to complete enrollment of its ongoing NeoCart Phase III clinical trial, which is being conducted under a Special Protocol Assessment with FDA.

This is an increase from 50% completion announced in mid-1Q16, after the 4Q15 amendment to the trial protocol to expand the eligible...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us